{"id":560,"date":"2025-06-29T17:21:04","date_gmt":"2025-06-29T17:21:04","guid":{"rendered":"https:\/\/www.saiep-paris.fr\/?p=560"},"modified":"2026-10-30T22:37:59","modified_gmt":"2026-10-30T22:37:59","slug":"continuous-optimization-leadership-shanghai-fosters-a-sound-business-environment-for-science-and-technology-and-develops-new-quality-productive-forces","status":"publish","type":"post","link":"https:\/\/www.saiep-paris.fr\/en\/continuous-optimization-leadership-shanghai-fosters-a-sound-business-environment-for-science-and-technology-and-develops-new-quality-productive-forces.html","title":{"rendered":"Continuing to \u201cOptimize + Lead\u201d: Shanghai Creates a Sound Science and Technology Business Environment and Develops New Quality Productive Forces"},"content":{"rendered":"<p><strong>2025 is the final year of the 14th Five-Year Plan and a key year for planning the high-quality development of the 15th Five-Year Plan.<\/strong><\/p>\n<p><strong>Centering on the goals of high-level scientific and technological self-reliance and the building of an international center of science and technology innovation, the Shanghai Municipal Science and Technology Commission thoroughly implements the work arrangements of the Municipal Party Committee and the Municipal Government on optimizing the business environment, continuously strengthens policy supply, guides the gathering of innovation factors, enhances the capacity for innovation sourcing, continuously optimizes the full-chain innovation service system, provides a fair, inclusive and universally beneficial innovation environment for all kinds of innovation entities, builds a cultivation system covering the entire life cycle of science and technology enterprise growth, and fosters a sound business environment.<\/strong><\/p>\n<p><strong>2025 is the final year of the 14th Five-Year Plan and a key year for planning the high-quality development of the 15th Five-Year Plan.<\/strong><\/p>\n<p><strong>Centering on the goals of high-level scientific and technological self-reliance and the building of an international center of science and technology innovation, the Shanghai Municipal Science and Technology Commission thoroughly implements the work arrangements of the Municipal Party Committee and the Municipal Government on optimizing the business environment, continuously strengthens policy supply, guides the gathering of innovation factors, enhances the capacity for innovation sourcing, continuously optimizes the full-chain innovation service system, provides a fair, inclusive and universally beneficial innovation environment for all kinds of innovation entities, builds a cultivation system covering the entire life cycle of science and technology enterprise growth, and fosters a sound business environment.<\/strong><\/p>\n<p><strong>Strong support: continuously strengthening top-level design and consolidating a full-chain policy supply system<\/strong><\/p>\n<section>\n<p>As the lead department for Shanghai&#8217;s biomedicine industry, the Shanghai Municipal Science and Technology Commission works with relevant departments to strengthen pioneering innovation reform, increase the policy supply supporting the high-quality development of the industry, focus on the bottlenecks and blockages in the industry&#8217;s development, deepen the coordinated reform and synergy of medical services, medical insurance and pharmaceuticals, and build a policy guarantee system supporting scientific and technological innovation and high-end industry leadership.<\/p>\n<p>In terms of scientific and technological innovation and industrial development in biomedicine, a number of policies have been formulated around the R&amp;D, industrialization and commercialization needs of innovative drugs and devices, consolidating the full-chain policy supply system. The General Office of the Shanghai Municipal People&#8217;s Government issued policies such as the \u201cSeveral Opinions of the General Office of the Shanghai Municipal People&#8217;s Government on Supporting the Full-Chain Innovative Development of the Biomedical Industry\u201d, the \u201cShanghai Action Plan for Enhancing the International Competitiveness of Biomedical Enterprises (2024-2027)\u201d, the \u201cShanghai Work Plan for Developing Medical Artificial Intelligence (2025-2027)\u201d and the \u201cShanghai Action Plan for Promoting the Innovative Development of Elderly Care Science and Technology (2024-2027)\u201d. Relevant municipal departments in Shanghai, in accordance with their own functions, have formulated and issued a series of policies on clinical trials, the inheritance of traditional Chinese medicine, medical cohorts, review and approval, ethical review, foreign-funded R&amp;D, equity investment, science and technology finance, customs facilitation, and environmental impact assessment and pollutant discharge, actively creating a sound innovation ecosystem for the biomedicine industry.<\/p>\n<p>The industry&#8217;s vitality continues to burst forth. In 2024, the output value of Shanghai&#8217;s biomedicine manufacturing industry reached RMB 201.167 billion, an increase of RMB 15.192 billion over 2023, or 3.3% growth on a comparable basis; advantageous fields such as therapeutic biological products and medical imaging equipment grew well. Two biomedical enterprises, Xiaofang Pharmaceutical and Innostellar, were listed on the main board of the Shanghai Stock Exchange and on the STAR Market respectively. Innovative products continued to gain momentum. In 2024, 7 domestic Class 1 innovative drugs were launched in the city (second in the country, accounting for 17.5% of the national total) and 3 imported Class 1 innovative drugs; 15 domestic Class III innovative medical devices were launched (first in the country, accounting for 32.6% of the national total) and 17 imported Class III innovative medical devices, with innovation results exceeding the same period last year. The capacity for international development continued to improve. There were 15 projects with overseas licensing transactions exceeding USD 500 million, with a transaction value of USD 19.833 billion, up 30.52% year on year and ranking first in the country.<\/p>\n<\/section>\n<section>\n<section>\n<section>\n<p>Strong momentum: continuously enhancing the function of scientific and technological innovation sourcing and strengthening science and technology finance support<\/p>\n<p><img referrerpolicy=\"no-referrer\" decoding=\"async\" src=\"https:\/\/www.saiep-paris.fr\/wp-content\/uploads\/2026\/11\/WX20250629-1922452x.jpg\" alt=\"\" \/><\/p>\n<\/section>\n<\/section>\n<\/section>\n<p>Shanghai: the sign of the \u201cDa Linghao Bay\u201d science and technology innovation sourcing function zone and related supporting facilities. Photo by Visual China Group\u00a0<\/p>\n<section>\n<p>Shanghai has studied and issued the \u201cSeveral Policy Measures on Accelerating the Construction of the \u201cDa Linghao Bay\u201d Science and Technology Innovation Sourcing Function Zone\u201d, forming specific policy measures around five aspects \u2014 \u201cstrengthening sourcing, promoting transformation, increasing momentum, gathering factors and creating atmosphere\u201d \u2014 with emphasis on increasing investment in basic research and supporting the transfer and transformation of scientific and technological achievements.<\/p>\n<p>Minhang District signed a new round of comprehensive cooperation framework agreements with 6 universities including Shanghai Jiao Tong University and East China Normal University, and introduced a number of basic science and technology innovation sourcing platforms such as the National Key Laboratory of RNA Functions and Applications of the Chinese Academy of Sciences; one-stop incubation platforms such as the Shanghai Jiao Tong University \u201cDa Linghao Bay\u201d one-kilometer incubator and the \u201cDa Linghao Bay\u201d achievement transformation base have been completed one after another.<\/p>\n<p>As the core carrier of Shanghai&#8217;s scientific and technological innovation sourcing function, Zhangjiang High-tech Zone has continuously improved its capacity for innovation sourcing. It gathers more than 300 high-level R&amp;D entities and hosts the world&#8217;s largest, most complete and most comprehensive cluster of photon large-scale scientific facilities.<\/p>\n<p>In addition, the concentration of high-quality enterprises in Zhangjiang High-tech Zone continues to increase, bringing together a number of leading enterprises such as Pinduoduo, Bilibili and Trip.com. By the end of 2023, the Zhangjiang National Innovation Demonstration Zone had 73 companies listed on the STAR Market, about 82% of the city&#8217;s total and 13% of the country&#8217;s; 435 listed companies at home and abroad, with one listed company per square kilometer on average; and 113 potential \u201cunicorn\u201d enterprises, accounting for more than 85% of the city&#8217;s total.<\/p>\n<p>Strong support from science and technology finance has been strengthened. Shanghai actively guides banks such as Shanghai Pudong Development Bank to support enterprise innovation, providing credit lines of RMB 4.098 billion to 204 little giant enterprises; Shanghai actively cultivates long-term capital and patient capital, gives play to the guiding role of government investment, and promotes the establishment and operation of a future industry fund with total scale of RMB 10 billion, accelerating a virtuous cycle of \u201cscience and technology \u2013 industry \u2013 finance\u201d. The \u201cgovernment + bank + insurance\u201d risk-sharing model has been continuously deepened; by the end of 2024, risk-sharing credit products such as the \u201cScience and Technology Innovation Support Loan\u201d and the \u201cScience and Technology Performance Loan\u201d had granted credit to 7,122 enterprises, with credit amounting to RMB 28.21 billion. The \u201cPujiang Light\u201d action has been implemented in depth, with 93 companies listed on the STAR Market in total and a combined market value of more than RMB 1.6 trillion, maintaining first place in the country.<\/p>\n<p>Focusing on the field of the modern industrial system, Shanghai supports science and technology service enterprises in making major project investments and in carrying out R&amp;D on key technologies, methods, devices and equipment, as well as digital and intelligent technological upgrading and equipment renewal.<\/p>\n<p>In 2024, a total of 16 major investment projects in science and technology services were supported, attracting enterprise investment of more than RMB 330 million; by adopting approaches such as \u201cenjoying benefits without application and enjoying benefits upon meeting standards\u201d, the municipal fiscal reward measures for science and technology service enterprises that reached the designated scale for the first time in 2024 were implemented more quickly, benefiting 127 enterprises.<\/p>\n<p>From January to November 2024, Shanghai had 2,465 science and technology service enterprises above the designated size, with revenue of RMB 540.959 billion, up 9.2% year on year; the year-on-year growth rate has climbed for three consecutive years (4.2% in 2022 and 8.6% in 2023), significantly higher than the national average of 5.9% over the same period.<\/p>\n<p>In 2025, Shanghai will further optimize the science and technology finance support system. It will give play to the early-stage investment and incubation function of the future industry fund, select and establish high-quality sub-funds, and identify, verify, incubate and invest in disruptive innovation projects at home and abroad. It will strengthen credit support for science and technology enterprises, make good use of the special fund policy for financing guarantees for science and technology innovation enterprises, and promote the implementation of the RMB 5 billion \u201cSpecial Guarantee Plan for Science and Technology Innovation\u201d of the Municipal Finance Bureau. It will optimize the product design of the \u201cScience and Technology Innovation Support Loan\u201d and encourage banks to use talent, R&amp;D intensity and achievement transformation capacity as loan thresholds for early-stage, small and hard-tech micro and small enterprises.<\/p>\n<\/section>\n<p>\u00a0<\/p>\n<section>\n<section>\n<section>\n<p>Strong effectiveness: taking multiple measures to promote the incubation and transformation of scientific and technological achievements<\/p>\n<\/section>\n<\/section>\n<\/section>\n<section>\n<p>Shanghai has deepened the reform of the property rights system for scientific and technological achievements, using a \u201csmall incision\u201d to leverage \u201cbig gains\u201d. It has implemented the \u201cImplementation Plan for the Pilot of Innovative Reform in the Transformation of Scientific and Technological Achievements in Shanghai\u201d, promoting reform measures such as granting full ownership under \u201cgranting ownership + transfer + agreement\u201d, and compliant entrepreneurship, and has encouraged pilot units to establish supporting institutional guidelines such as separate management of scientific and technological achievements and exemption from liability for due diligence. The pilot stage of the reform achieved remarkable results in 2024: 39 pilot units \u2014 universities, research institutes and medical and health institutions \u2014 were granted rights over 185 achievements, including 82 with full ownership granted, with a transformation value of RMB 1.09 billion, and 149 companies were set up through researchers&#8217; independent entrepreneurship or compliant restructuring, attracting investment and financing of RMB 6.8 billion.<\/p>\n<p>In terms of the transformation of scientific and technological achievements, a number of representative transformation cases have emerged in Shanghai. In 2024, the \u201c7-azaindole compounds and their preparation methods and applications\u201d jointly developed by research teams from Fudan University and East China Normal University were exclusively licensed to a pharmaceutical company for USD 98.25 million. The value of scientific and technological achievements transformed by East China Normal University through licensing, transfer and investment in kind increased from RMB 7.08 million in 2023 to RMB 476 million in 2024; after Shanghai University of Science and Technology issued its rights-granting document, the first fully rights-granted achievement, the \u201chumanoid robot project\u201d, completed RMB 100 million in financing in only two months; Ruijin Hospital concluded two transformation contracts worth RMB 100 million or more: a RMB 270 million transformation agreement with Shanghai Pharmaceuticals Ruier on a \u201cgene therapy for hemophilia\u201d technical solution, and a RMB 100 million patent package transformation cooperation with Shanghai RAAS Blood Products on \u201ccoagulation and anticoagulation drugs\u201d; Renji Hospital issued the \u201cImplementation Rules for the Separate Management of Scientific and Technological Achievements of Official Duties\u201d, more than doubling approval efficiency.<\/p>\n<p>Around the modern industrial system and focusing on frontier tracks and future industries such as gene therapy, intelligent sensing, large models and humanoid robots, Shanghai has launched the construction of a number of high-quality incubators.<\/p>\n<p>Shanghai strengthens enterprise-centered \u201cindustry-academia-research\u201d cooperation, gives play to enterprises as \u201cquestion setters\u201d, \u201cexaminers\u201d and \u201canswerers\u201d, accelerates the building of an open industrial innovation ecosystem with enterprises at the core, and supports leading enterprises such as COMAC, CCB Fintech and Henlius to take the lead in forming innovation consortia; it focuses on cultivating a number of ecosystem-leading enterprises in the industrial chain with strong original creativity, and supports large enterprises in building open innovation platforms.<\/p>\n<p>In 2025, the Shanghai Municipal Science and Technology Commission will continue to advance the building of the technology transfer system to high standards. It will promote the market-based allocation of technology factors, support the Shanghai Technology Exchange in building a national trading center for intellectual property and scientific and technological achievement property rights, and explore facilitation measures such as cross-border technology trade; it will build an international technology transfer collaboration network, carry out cross-border promotion and implementation services for scientific and technological achievements on a regular basis, and promote global information exchange and transformation and application of scientific and technological achievements.<\/p>\n<p>Shanghai will improve the mechanism supporting the development of innovative drugs, better leverage their clinical benefits and enhance people&#8217;s wellbeing. Relying on the comprehensive reform advantages of Pudong New Area and seeking the support of relevant national departments, it will take the lead in carrying out reform on the hospital admission and use of innovative drugs. Adhering to the basic principles of putting people first, giving priority to innovation, piloting first and keeping risks controllable, and focusing on key links such as the hospital admission, use, pricing, payment and review and approval of innovative drugs, it will strengthen the coordination of the \u201cthree medicals\u201d and, with the stance of a pioneer and the responsibility of a forerunner, actively \u201ctest systems, measure pressure and explore new paths\u201d for the country, accelerate the building of a biomedical industry innovation highland with global influence, and cultivate and develop new quality productive forces.<\/p>\n<\/section>\n<section>\n<section data-mpa-template=\"t\"><\/p>\n<section data-mpa-template=\"t\">\n<section data-mpa-template=\"t\">\n<hr \/>\n<p>Source: The Paper<\/p>\n<p>Reporter: Wu Yuewei<\/p>\n<p>Editor: Shi<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>2025 is the final year of the 14th Five-Year Plan and a key year for planning the high-quality development of the 15th Five-Year Plan. Centering on the goals of high-level scientific and technological self-reliance and the building of an international center of science and technology innovation, the Shanghai Municipal Science and Technology Commission thoroughly implements the work arrangements of the Municipal Party Committee and the Municipal Government on optimizing the business environment, continuously strengthens policy supply, guides the gathering of innovation factors, enhances the capacity for innovation sourcing, continuously optimizes [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[37],"tags":[],"class_list":["post-560","post","type-post","status-publish","format-standard","hentry","category-2018-04-04-14-14-44"],"_links":{"self":[{"href":"https:\/\/www.saiep-paris.fr\/en\/wp-json\/wp\/v2\/posts\/560","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.saiep-paris.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.saiep-paris.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.saiep-paris.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.saiep-paris.fr\/en\/wp-json\/wp\/v2\/comments?post=560"}],"version-history":[{"count":3,"href":"https:\/\/www.saiep-paris.fr\/en\/wp-json\/wp\/v2\/posts\/560\/revisions"}],"predecessor-version":[{"id":2540,"href":"https:\/\/www.saiep-paris.fr\/en\/wp-json\/wp\/v2\/posts\/560\/revisions\/2540"}],"wp:attachment":[{"href":"https:\/\/www.saiep-paris.fr\/en\/wp-json\/wp\/v2\/media?parent=560"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.saiep-paris.fr\/en\/wp-json\/wp\/v2\/categories?post=560"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.saiep-paris.fr\/en\/wp-json\/wp\/v2\/tags?post=560"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}